TuisGEKA • FRA
add
Genomma Lab Internacional SAB de CV
Vorige sluiting
€0,89
Dagwisseling
€0,83 - €0,83
Jaarwisseling
€0,76 - €1,09
Markkapitalisasie
16,83 mjd MXN
Gemiddelde volume
28,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
BMV
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (MXN) | Mrt. 2026info | J/J-verandering |
|---|---|---|
Inkomste | 4,19 mjd | -4,90% |
Bedryfskoste | — | — |
Netto inkomste | — | — |
Netto winsgrens | 11,80 | 4,24% |
Wins per aandeel | 0,49 | -2,00% |
EBITDA | — | — |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (MXN) | Mrt. 2026info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | — | — |
Totale bates | — | — |
Totale aanspreeklikheid | — | — |
Totale ekwiteit | — | — |
Uitstaande aandele | — | — |
Prys om te bespreek | — | — |
Opbrengs op bates | 8,99% | — |
Opbrengs op kapitaal | 11,37% | — |
Kontantvloei
Netto kontantverandering
| (MXN) | Mrt. 2026info | J/J-verandering |
|---|---|---|
Netto inkomste | — | — |
Kontant van bedrywe | — | — |
Kontant van beleggings | — | — |
Kontant van finansiering | — | — |
Netto kontantverandering | — | — |
Beskikbare kontantvloei | — | — |
Meer oor
Genomma Lab Internacional or simply Genomma Lab is a Mexican company, founded in 1996, dedicated to the commercialization of OTC medications and dermocosmetic products. It is part of the Índice de Precios y Cotizaciones, the main stock index of the Mexican Stock Exchange. It is one of the leading pharmaceutical companies in the country.
Genomma Lab Internacional, led by its owner Rodrigo Alonso Herrera Aspra, recorded net sales of 9,799.7 million Mexican pesos, equivalent to 756.0 million USD in 2012, achieving a 21.6% growth compared to 2011. Currently, Genomma Lab operates in 15 countries outside Mexico and has achieved success by replicating its business model. Wikipedia
Gestig
1996
Webwerf
Werknemers
1 643
